Somatostatin Analogues in Pancreatic Neuroendocrine Tumors

0 Views
administrator
administrator
07/13/23

In this segment, Rodney Pommier, MD, and J. Philip Boudreaux, MD, review the role of somatostatin analogues and their adverse events in treating pancreatic neuroendocrine tumors.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next